QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)

ADiTx Therapeutics News Headlines

$1.58
+0.03 (+1.94 %)
(As of 10/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.52
$1.61
50-Day Range
$1.54
$3.04
52-Week Range
$1.51
$6.73
Volume2.08 million shs
Average Volume3.07 million shs
Market Capitalization$23.21 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Media Mentions By Week

ADiTx Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ADTX
News Sentiment

1.60

0.37

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ADTX Articles
This Week

1

0

ADTX Articles
Average Week

Get ADiTx Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter.

ADiTx Therapeutics (NASDAQ ADTX) News Headlines Today

SourceHeadline
finance.yahoo.com logoAditxt Announces Pricing of $4.25 Million Public Offering
finance.yahoo.com - October 18 at 7:56 AM
finance.yahoo.com logoAditxt to Present at the LD Micro Main Event in Los Angeles on October 13, 2021
finance.yahoo.com - October 7 at 1:35 PM
finance.yahoo.com logoAiPharma Signs Binding Agreement To Sell To Aditxt Inc (Nasdaq: ADTX). AiPharma Is The Rights Holder Of Antiviral Tablet Avigan / Reeqonus / Qifenda That Has Treated Over 1.5M COVID-19 Patients Since The Outbreak.
finance.yahoo.com - October 6 at 1:09 PM
MarketBeat logoADiTx Therapeutics Sees Unusually Large Options Volume (NASDAQ:ADTX)
americanbankingnews.com - October 5 at 1:34 PM
markets.businessinsider.com logoAditxt Enters Transaction Agreement To Acquire AiPharma - Quick Facts
markets.businessinsider.com - October 5 at 12:06 PM
finance.yahoo.com logoAditxt Signs a Transaction Agreement to Acquire AiPharma, Rights Holder of Antiviral Tablet Avigan/Reeqonus/Qifenda Used in the Treatment of Over 1.5 Million COVID-19 Patients Outside the U.S. and Canada
finance.yahoo.com - October 5 at 12:06 PM
MarketBeat logoADiTx Therapeutics, Inc. (NASDAQ:ADTX) Short Interest Update
americanbankingnews.com - October 2 at 6:58 AM
finance.yahoo.com logoAditxt Appoints Corinne Pankovcin as President and Thomas J. Farley as Chief Financial Officer as Company Prepares for Global Commercialization
finance.yahoo.com - September 27 at 1:04 PM
finance.yahoo.com logoAditxt, Inc. and SphereDX Launch AditxtScore™ for COVID-19 in Kentucky, Ohio and Indiana to Address Individual Immune Status Uncertainty and Help Evaluate Cadence for Booster Shots
finance.yahoo.com - September 9 at 10:02 AM
benzinga.com logoWhat Is Happening With Crypto Today?
benzinga.com - September 8 at 10:54 PM
finance.yahoo.com logoAditxt Announces Closing of $11 Million Registered Direct Offering, and Funding of Bridge Loan Satisfying a Key Term of its Letter of Intent for Planned Acquisition of Commercial Stage Pharma Company with Anti-Viral COVID-19 Therapy
finance.yahoo.com - September 7 at 4:49 PM
finance.yahoo.com logoAditxt Announces Pricing of $11.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
finance.yahoo.com - August 26 at 12:40 PM
finance.yahoo.com logoAditxt, Inc. Signs Letter of Intent for Exclusive Rights to Negotiate the Acquisition of a Biopharmaceutical Company Commercializing and Distributing Antiviral Oral Therapy for COVID-19
finance.yahoo.com - August 25 at 10:24 AM
barrons.com logoAditxt Inc.
barrons.com - August 21 at 4:20 PM
finance.yahoo.com logoAditxt, Inc. and Great Lakes Medical Laboratory Launch AditxtScore for COVID-19 in State of Michigan as a Personalized Approach to Addressing COVID-19 Pandemic
finance.yahoo.com - August 11 at 9:47 AM
finance.yahoo.com logoAditxt Provides Update on AditxtReprogramming’s™ Apoptotic DNA Immunotherapy Therapeutic Platform
finance.yahoo.com - August 4 at 8:19 AM
finance.yahoo.com logoAditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA
finance.yahoo.com - July 7 at 8:21 AM
finance.yahoo.com logoAditxt Announces the Appointment of Dr. Lauren Chung to its Board of Directors
finance.yahoo.com - June 18 at 8:18 AM
finance.yahoo.com logoAditxt Set to Join Russell Microcap® Index
finance.yahoo.com - June 15 at 12:26 PM
barrons.com logoADiTx Therapeutics Inc.
barrons.com - June 10 at 12:02 AM
finance.yahoo.com logoAditxt Signs Channel Partner Agreement with Meridian HSN to Make AditxtScore™ for COVID-19 Available to its Network of Healthcare Provider Partners
finance.yahoo.com - May 6 at 8:48 AM
finance.yahoo.com logoAditxt to Establish State-of-the-Art Immune Monitoring Center in Richmond, VA
finance.yahoo.com - May 3 at 6:18 PM
investorplace.com logoAditx Therapeutics Inc (ADTX)
investorplace.com - April 21 at 12:02 AM
finance.yahoo.com logoAditxt Therapeutics Names Sunny Uberoi as its first Chief Communications Officer
finance.yahoo.com - April 13 at 12:08 PM
finance.yahoo.com logoHealthBar Becomes AditxtScore™ Channel Partner to Offer AditxtScore™ for COVID-19 Immunity Status Monitoring to Complement its Concierge and Drive-Thru Testing Services
finance.yahoo.com - April 6 at 11:11 AM
finance.yahoo.com logoAditxt to Initiate First-In-Human Clinical Trials with its Therapeutics Programs in Psoriasis by Year-End
finance.yahoo.com - March 24 at 12:56 PM
finance.yahoo.com logoAditx Therapeutics Stock Is Trading Higher On Initiating Human Trials With Psoriasis Candidate By 2021
finance.yahoo.com - March 24 at 12:56 PM
finance.yahoo.com logoAditxt Announces Participation in the Benzinga Biotech Small Cap Conference
finance.yahoo.com - March 22 at 1:22 PM
finance.yahoo.com logoEazy Testing Inc. Becomes AditxtScore™ Channel Partner, to Offer AditxtScore™ for COVID-19 Immunity Status Monitoring with its Walk-In, Concierge, and Pre-Flight Services
finance.yahoo.com - March 4 at 12:17 PM
finance.yahoo.com logoImmunologist and Clinical Transplant Expert, Dolly B. Tyan, PhD, Joins Aditxt as Senior VP of Clinical Development - Transplantation
finance.yahoo.com - January 29 at 2:08 PM
marketwatch.com logoAditxt Secures $5 Million Financing to Scale AditxtScore Operational Capacity
marketwatch.com - January 26 at 10:19 PM
finance.yahoo.com logoAditxt Secures $5 Million Financing to Scale AditxtScore™ Operational Capacity
finance.yahoo.com - January 26 at 12:19 PM
msn.com logoWhy ADiTx Shares Are Rallying To A 5-Month High
msn.com - January 21 at 2:34 PM
finance.yahoo.com logoAditxtScore™ Immune Monitoring Service Will be Operational on February 1st
finance.yahoo.com - January 21 at 9:34 AM
proactiveinvestors.com logoTodos Medical forms distribution agreement with coronavirus immunity-focused Aditx Therapeutics
proactiveinvestors.com - December 14 at 8:18 PM
finance.yahoo.com logoAditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore™ for COVID-19 Immune Monitoring Service
finance.yahoo.com - December 14 at 8:11 AM
benzinga.com logoWhy ADiTx Therapeutics's Stock is Trading Higher Today
benzinga.com - December 11 at 1:15 PM
finance.yahoo.com logoAditxt to Present at the 13th Annual LD Micro Main Event Conference
finance.yahoo.com - December 8 at 5:25 PM
finance.yahoo.com logoPhysician and Media Personality Dr. Drew and Aditxt CEO to Reveal and Discuss Their Personal AditxtScore™ for COVID-19 Results During AditxtEngage™ Live Event on Tuesday, December 1st at 10:00 am ET
finance.yahoo.com - November 30 at 9:28 AM
finance.yahoo.com logoWe're Not Very Worried About ADiTx Therapeutics' (NASDAQ:ADTX) Cash Burn Rate
finance.yahoo.com - November 23 at 3:49 PM
finance.yahoo.com logoAditxt Appoints Anthony Voorhies as Head of Business Development for AditxtScore™
finance.yahoo.com - November 20 at 12:36 PM
finance.yahoo.com logoAditxt Secures CLIA Certification for AditxtScore™ Laboratory Operations in Richmond, VA, and Plans to Launch AditxtScore™ for COVID-19 as a Lab Developed Test (LDT)
finance.yahoo.com - November 19 at 10:19 AM
markets.businessinsider.com logoAditxt Provides Business Update and Files Third Quarter 2020 10-Q
markets.businessinsider.com - November 13 at 8:18 AM
finance.yahoo.com logoFormer Chief Medical Officer and Assistant Secretary for Health Affairs of the U.S. Department of Homeland Security, Dr. Jeffrey Runge, Appointed to Aditxt Board of Directors
finance.yahoo.com - October 18 at 11:47 PM
finance.yahoo.com logoAditxt Announces First AditxtEngage™ Event, Continuing Series of Investor Opportunities to Engage with Company
finance.yahoo.com - October 18 at 11:47 PM
finance.yahoo.com logoAditx Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference
finance.yahoo.com - September 10 at 5:39 PM
finance.yahoo.com logoPhysician and Media Personality Dr. Drew Pinsky, Dr. Drew, Joins Aditx Therapeutics as Senior Advisor to AditxtScore™ for Scoring the Immune System
finance.yahoo.com - September 10 at 12:38 PM
finance.yahoo.com logoAditx Therapeutics Announces Closing of Upsized $9.6 Million Follow-On Public Offering
finance.yahoo.com - September 10 at 12:38 PM
finance.yahoo.com logoAditxt Signs Collaboration Agreement with Salveo Diagnostics to Commercialize AditxtScore™ Platform Starting in Q4, 2020
finance.yahoo.com - September 3 at 12:54 PM
finance.yahoo.com logoAditx Therapeutics Announces Pricing of $9.6 Million Follow-On Public Offering
finance.yahoo.com - September 2 at 10:05 AM
Get ADiTx Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.